189 related articles for article (PubMed ID: 38398085)
1. Cancer Cell Biomechanical Properties Accompany Tspan8-Dependent Cutaneous Melanoma Invasion.
Runel G; Lopez-Ramirez N; Barbollat-Boutrand L; Cario M; Durand S; Grimont M; Schartl M; Dalle S; Caramel J; Chlasta J; Masse I
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398085
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion.
Berthier-Vergnes O; El Kharbili M; de la Fouchardière A; Pointecouteau T; Verrando P; Wierinckx A; Lachuer J; Le Naour F; Lamartine J
Br J Cancer; 2011 Jan; 104(1):155-65. PubMed ID: 21081927
[TBL] [Abstract][Full Text] [Related]
3. p53 targets TSPAN8 to prevent invasion in melanoma cells.
Agaësse G; Barbollat-Boutrand L; El Kharbili M; Berthier-Vergnes O; Masse I
Oncogenesis; 2017 Apr; 6(4):e309. PubMed ID: 28368391
[TBL] [Abstract][Full Text] [Related]
4. Tspan8 Drives Melanoma Dermal Invasion by Promoting ProMMP-9 Activation and Basement Membrane Proteolysis in a Keratinocyte-Dependent Manner.
El Kharbili M; Cario M; Béchetoille N; Pain C; Boucheix C; Degoul F; Masse I; Berthier-Vergnes O
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455575
[TBL] [Abstract][Full Text] [Related]
5. Tetraspanin 8 is a novel regulator of ILK-driven β1 integrin adhesion and signaling in invasive melanoma cells.
El Kharbili M; Robert C; Witkowski T; Danty-Berger E; Barbollat-Boutrand L; Masse I; Gadot N; de la Fouchardière A; McDonald PC; Dedhar S; Le Naour F; Degoul F; Berthier-Vergnes O
Oncotarget; 2017 Mar; 8(10):17140-17155. PubMed ID: 28188308
[TBL] [Abstract][Full Text] [Related]
6. Critical role of glioma-associated oncogene homolog 1 in maintaining invasive and mesenchymal-like properties of melanoma cells.
Gunarta IK; Li R; Nakazato R; Suzuki R; Boldbaatar J; Suzuki T; Yoshioka K
Cancer Sci; 2017 Aug; 108(8):1602-1611. PubMed ID: 28635133
[TBL] [Abstract][Full Text] [Related]
7. EMT-associated factors promote invasive properties of uveal melanoma cells.
Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
[TBL] [Abstract][Full Text] [Related]
8. NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines.
Huergo-Zapico L; Parodi M; Cantoni C; Lavarello C; Fernández-Martínez JL; Petretto A; DeAndrés-Galiana EJ; Balsamo M; López-Soto A; Pietra G; Bugatti M; Munari E; Marconi M; Mingari MC; Vermi W; Moretta L; González S; Vitale M
Cancer Res; 2018 Jul; 78(14):3913-3925. PubMed ID: 29752261
[TBL] [Abstract][Full Text] [Related]
9. Increased plasticity of the stiffness of melanoma cells correlates with their acquisition of metastatic properties.
Weder G; Hendriks-Balk MC; Smajda R; Rimoldi D; Liley M; Heinzelmann H; Meister A; Mariotti A
Nanomedicine; 2014 Jan; 10(1):141-8. PubMed ID: 23891982
[TBL] [Abstract][Full Text] [Related]
10. CD63 tetraspanin is a negative driver of epithelial-to-mesenchymal transition in human melanoma cells.
Lupia A; Peppicelli S; Witort E; Bianchini F; Carloni V; Pimpinelli N; Urso C; Borgognoni L; Capaccioli S; Calorini L; Lulli M
J Invest Dermatol; 2014 Dec; 134(12):2947-2956. PubMed ID: 24940653
[TBL] [Abstract][Full Text] [Related]
11. Tspan8-β-catenin positive feedback loop promotes melanoma invasion.
El Kharbili M; Agaësse G; Barbollat-Boutrand L; Pommier RM; de la Fouchardière A; Larue L; Caramel J; Puisieux A; Berthier-Vergnes O; Masse I
Oncogene; 2019 May; 38(20):3781-3793. PubMed ID: 30679790
[TBL] [Abstract][Full Text] [Related]
12. The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype.
Vandamme N; Denecker G; Bruneel K; Blancke G; Akay Ö; Taminau J; De Coninck J; De Smedt E; Skrypek N; Van Loocke W; Wouters J; Nittner D; Köhler C; Darling DS; Cheng PF; Raaijmakers MIG; Levesque MP; Mallya UG; Rafferty M; Balint B; Gallagher WM; Brochez L; Huylebroeck D; Haigh JJ; Andries V; Rambow F; Van Vlierberghe P; Goossens S; van den Oord JJ; Marine JC; Berx G
Cancer Res; 2020 Jul; 80(14):2983-2995. PubMed ID: 32503808
[TBL] [Abstract][Full Text] [Related]
13. Intrinsic Balance between ZEB Family Members Is Important for Melanocyte Homeostasis and Melanoma Progression.
Bruneel K; Verstappe J; Vandamme N; Berx G
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32796736
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
[TBL] [Abstract][Full Text] [Related]
15. EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment.
Tang Y; Durand S; Dalle S; Caramel J
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32759677
[TBL] [Abstract][Full Text] [Related]
16. Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1.
Jose CC; Jagannathan L; Tanwar VS; Zhang X; Zang C; Cuddapah S
Mol Carcinog; 2018 Jun; 57(6):794-806. PubMed ID: 29528143
[TBL] [Abstract][Full Text] [Related]
17. Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma.
Siena ÁDD; Plaça JR; Araújo LF; de Barros II; Peronni K; Molfetta G; de Biagi CAO; Espreafico EM; Sousa JF; Silva WA
Sci Rep; 2019 Aug; 9(1):11350. PubMed ID: 31383874
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-3662 targets ZEB1 and attenuates the invasion of the highly aggressive melanoma cell line A375.
Zhu L; Liu Z; Dong R; Wang X; Zhang M; Guo X; Yu N; Zeng A
Cancer Manag Res; 2019; 11():5845-5856. PubMed ID: 31388313
[TBL] [Abstract][Full Text] [Related]
19. ZEB1-mediated melanoma cell plasticity enhances resistance to MAPK inhibitors.
Richard G; Dalle S; Monet MA; Ligier M; Boespflug A; Pommier RM; de la Fouchardière A; Perier-Muzet M; Depaepe L; Barnault R; Tondeur G; Ansieau S; Thomas E; Bertolotto C; Ballotti R; Mourah S; Battistella M; Lebbé C; Thomas L; Puisieux A; Caramel J
EMBO Mol Med; 2016 Oct; 8(10):1143-1161. PubMed ID: 27596438
[TBL] [Abstract][Full Text] [Related]
20. The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.
Ramsdale R; Jorissen RN; Li FZ; Al-Obaidi S; Ward T; Sheppard KE; Bukczynska PE; Young RJ; Boyle SE; Shackleton M; Bollag G; Long GV; Tulchinsky E; Rizos H; Pearson RB; McArthur GA; Dhillon AS; Ferrao PT
Sci Signal; 2015 Aug; 8(390):ra82. PubMed ID: 26286024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
